you are here:
Success
Alert
Please select a Day.
Info
591.50
21.35 (3.74%)

As on 07 May, 2021 | 03:59

Trade
Day Range
565.10
602.70
L H
52 Week Range
325.55
602.70
L H
Volume
12,763,132
*
i

* BSE Market Depth (07 May 2021)

BUY SELL
QTY PRICE PRICE QTY
66 591.85 592.95 21
100 591.80 593.00 17
77 591.00 593.50 116
50 590.80 593.90 50
20 590.50 594.00 99
7349 Total Total 15895
Bid / Ask
591.80 / 591.80
591.80
21.85 (3.83%)

As on 07 May, 2021 | 04:00

Day Range
565.50
602.40
L H
52 Week Range
322.90
602.40
L H
Volume
494,235
*
i

* BSE Market Depth (07 May 2021)

BUY SELL
QTY PRICE PRICE QTY
66 591.85 592.95 21
100 591.80 593.00 17
77 591.00 593.50 116
50 590.80 593.90 50
20 590.50 594.00 99
7349 Total Total 15895
Bid / Ask
591.80 / 591.80
--
-- (--%)

As on --

Day Range
--
--
L H
Open Interest Analysis
Long Unwinding

(OI , PRICE )

See Historical Trend

Volume
--
--
-- (--%)

As on --

Day Range
--
--
L H
Moneyness
--
Volume
--
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Financials
    Ownerships
      Industry Comparison
        Others
          Open571.00
          Previous Close570.15
          UC Limit627.15
          LC Limit513.15
          Volume12,763,132.00
          VWAP593.09
          Mkt Cap (Rs. Cr.)16,690
          20D Avg Volume5,809,667
          20D Avg Delivery1,085,148
          Beta0.830.72
          Face Value1.00
          TTM EPS33.90
          TTM PE17.45
          Sector PE41.59
          Book Value Per Share215.12
          P/B2.75
          Dividend Yield0.42
          P/C12.15

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages
          • 81.69% away from 52 week low
          • 1.86% away from 52 week high
          • Outperformer - Glenmark Pharma up by 17.44% v/s NIFTY 50 up by 0.03% in last 1 month
          • F&O data suggests Long Buildup today
          • Stock saw 47 number of Large Deals today.Tap to see details.
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          5

          indicates Average Financials

          3 year CAGR growth
          Revenue 5.8%
          NetProfit -11.2%
          OperatingProfit -5.9%
          Industry Comparison
          • TTM PE Ratio - Above industry Median
          • Market Cap - High in industry
          • Price to Book Ratio - Below industry Median
          • TTM PEG Ratio - Above industry Median
          Shareholding Pattern
          • Promoters holding remains unchanged at 46.63% in Mar 2021 qtr
          • Mutual Funds have decreased holdings from 3.33% to 3.27% in Mar 2021 qtr
          • Number of MF schemes remains unchanged at 16 in Mar 2021 qtr
          • FII/FPI have decreased holdings from 26.48% to 25.84% in Mar 2021 qtr
          • Number of FII/FPI investors decreased from 300 to 294 in Mar 2021 qtr
          • Institutional Investors have decreased holdings from 35.91% to 35.0% in Mar 2021 qtr

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis

          News

          Forum

          Community Sentiments

          • 76% BUY
          • 7% SELL
          • 17% HOLD
          76%
          of moneycontrol users recommend buying Glenmark

          What's your call on Glenmark today?

          Read 65 investor views

          BUY SELL HOLD

          Deals

          04 Jun, 2018

          AL MEHWAR COMMERCIAL INVSTMENTS LLC NOOSA

          Qty 970000 Price 535 % Traded 0.34
          04 Jun, 2018

          ABU DHABI INVESTMENT COUNCIL NOOSA

          Qty 970000 Price 535 % Traded 0.34
          23 Aug, 2016

          HSBC GLOBAL INVESTMENT FUNDS INDIAN EQUITY

          Qty 1100000 Price 855 % Traded 0.39
          23 Aug, 2016

          HSBC GLOBAL INVESTMENT FU NDS MAURITIUS LTD

          Qty 1100000 Price 855 % Traded 0.39
          06 Nov, 2012

          THE ROYAL BANK OF SCOTLAND ASIA MERCHANT BANK SINGAPORE LT

          Qty 815685 Price 438.1 % Traded 0.29
          06 Nov, 2012

          ABN AMRO BANK NV

          Qty 815685 Price 438.1 % Traded 0.29
          25 Oct, 2012

          THE ROYAL BANK OF SCOTLAND ASIA MERCHANT BANK SINGAPORE LT

          Qty 400000 Price 399 % Traded 0.14
          25 Oct, 2012

          ABN AMRO BANK NV

          Qty 400000 Price 399 % Traded 0.14

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          24 Jun, 2020

          CENTILLION RESEARCH INDIA LLP

          Qty 1502024 Price 465.46 % Traded 0.53
          24 Jun, 2020

          CENTILLION RESEARCH INDIA LLP

          Qty 1502024 Price 465.63 % Traded 0.53
          23 Jun, 2020

          SHADOWFAX ADVERTISERS PRIVATE LIMITED

          Qty 3449645 Price 500.63 % Traded 1.22
          23 Jun, 2020

          ALPHAGREP SECURITIES PRIVATE LIMITED

          Qty 2918705 Price 499.24 % Traded 1.03
          23 Jun, 2020

          SURJECTIVE RESEARCH CAPITAL LLP

          Qty 2720020 Price 495.64 % Traded 0.96
          23 Jun, 2020

          CENTILLION RESEARCH INDIA LLP

          Qty 2431725 Price 494.59 % Traded 0.86
          23 Jun, 2020

          GRAVITON RESEARCH CAPITAL LLP

          Qty 2166286 Price 492.61 % Traded 0.77
          23 Jun, 2020

          HRTI PRIVATE LIMITED

          Qty 1905536 Price 498.19 % Traded 0.68

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Insider Transaction Summary

          Nov, 16, 2020

          AISHA LOUISE SALDANHA

          Promoters Immediate Relative
          Qty 10000 Price 487.72 % Traded 0.00 Post Tnx Hold. 0%
          Nov, 16, 2020

          RAYNA MARIE SALDANHA

          Promoters Immediate Relative
          Qty 10000 Price 487.75 % Traded 0.00 Post Tnx Hold. 0%
          Sep, 28, 2020

          ROBIN PINTO

          Promoter Group
          Qty 250 Price 451.33 % Traded 0.00 Post Tnx Hold. 0.18%
          Sep, 23, 2020

          ROBIN PINTO

          Promoter Group
          Qty 250 Price 465.02 % Traded 0.00 Post Tnx Hold. 0.18%
          Sep, 07, 2020

          ROBIN PINTO

          Promoter Group
          Qty 500 Price 479.41 % Traded 0.00 Post Tnx Hold. 0.18%
          Aug, 31, 2020

          ROBIN PINTO

          Promoter Group
          Qty 500 Price 500.47 % Traded 0.00 Post Tnx Hold. 0.18%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Oct, 05, 2020

          HSBC Global Asset Management (Hong Kong) Ltd

          null
          Qty 204615 Price 0 % Traded 0.07 Post Tnx Hold. 5.04%
          Feb, 23, 2018

          HSBC Global Asset Management (Hong Kong) Ltd

          null
          Qty 143030 Price 0 % Traded 0.05 Post Tnx Hold. 5%
          Oct, 10, 2017

          Oppenheimer Funds,Inc. (F.I.I)

          Other
          Qty 160000 Price 0 % Traded 0.06 Post Tnx Hold. 3.01%
          Feb, 06, 2017

          Oppenheimer Funds,Inc (F.I.I)

          Other
          Qty 74647 Price 0 % Traded 0.03 Post Tnx Hold. 5.01%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          • Revenue
          • Net Profit
          • EPS
          • Revenue
          • Net Profit
          • EPS

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          Glenmark 591.50 3.74 16690.25 10.07 1.26 10.24 75.94 1,354 6,712 0.27
          Sun Pharma 679.45 0.01 163022.81 63.62 3.32 8.31 50.25 4,186 32,837 0.17
          Divis Labs 4029.10 -0.84 106959.95 57.18 14.63 18.83 78.37 1,376 5,394 0.00
          Dr Reddys Labs 5174.70 0.12 86055.90 39.56 5.52 12.98 34.84 1,969 17,517 0.11
          Cipla 882.90 -0.16 71202.64 31.83 4.45 9.81 49.76 1,546 17,131 0.18

          About the Company

          Glenmark Pharmaceuticals Ltd has a significant presence in the branded generics markets across emerging economies including India.The company entered into the dermatology market through the launch of its Candid Cream.Glenmarks ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain].The formulations business of the company focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology. India is the largest market in terms of revenue for the organization.
          {"success":1,"data":{"address":{"address1":"B\/2, Mahalaxmi Chambers,","address2":"22, Bhulabhai Desai Road,,","city":"Mumbai","state":"Maharashtra","pincode":"400026","telephone1":"022-40189999","telephone2":"022-40189879","fax1":"022-40189986","fax2":"","email":"csr@glenmarkpharma.com","web":"http:\/\/www.glenmarkpharma.com"},"management":[{"name":"Glenn Saldanha","designation":"Chairman & Managing Director"},{"name":"Cherylann Pinto","designation":"Executive Director - Corporate Affairs"},{"name":"V S Mani","designation":"Executive Director & Global CFO"},{"name":"Rajesh V Desai","designation":"Non Executive Director"},{"name":"Brian W Tempest","designation":"Non Executive Director"}],"registrars":{"name":"Karvy Computershare Private Ltd.","address1":"Karvy Selenium Tower B","address2":"Plot no. 31-32, Gachibowli","address3":"Financial District","address4":"Nanakramguda","telephone":"040-23001153","fax":"","email":"","internet":"","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"Yes"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"Yes"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"532296","nseId":"GLENMARK","series":"EQ","isinid":"INE935A01035"}}}
          • Registered Office

          • Registrars

            • Address

              Karvy Selenium Tower B,Plot no. 31-32, Gachibowli

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-23001153

            • Fax No.

            • Email

            • Internet

          • Management

            • Glenn Saldanha

              Chairman & Managing Director

            • Cherylann Pinto

              Executive Director - Corporate Affairs

            • V S Mani

              Executive Director & Global CFO

            • Rajesh V Desai

              Non Executive Director

            • Brian W Tempest

              Non Executive Director

          • Included In

            • BSE 100

              Yes

            • BSE 200

              Yes

            • SENSEX

              No

            • CNX MIDCAP 200

              Yes

            • NIFTY 50

              No

            • BSE 500

              Yes

          • Details

            • BSE:

              532296

            • NSE:

              GLENMARK

            • Series

              EQ

            • ISIN

              INE935A01035

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>